Department of Endocrinology, School of Medical Sciences, Örebro University, SE 70182, Örebro, Sweden.
Department of Pediatrics, School of Medical Sciences, Örebro University, SE 70182, Örebro, Sweden.
Endocrine. 2018 Sep;61(3):388-397. doi: 10.1007/s12020-018-1665-6. Epub 2018 Jul 5.
Several observational studies have shown an association between vitamin D deficiency and non-skeletal major health issues including impaired cardiorespiratory fitness and adiposity. Only a few studies have examined the impact of vitamin D supplementation on these conditions and the results are ambiguous. The aim of this study was to examine the effect of vitamin D supplementation on body composition and cardiorespiratory fitness in overweight/obese men with vitamin D deficiency.
This study was a prospective, placebo controlled, double blinded, randomized trial with a study period of 6 months. Forty overweight/obese men (BMI > 25 kg/m) with vitamin D deficiency (25(OH)D ≤ 55 nmol/L) were randomized to receive either 2000 IU Cholecalciferol drops or the equivalent amount of drops of placebo. At baseline and follow up body composition and cardiorespiratory fitness were measured and blood samples were obtained. Body composition was measured using bioelectrical impedance analysis (BIA) and cardiorespiratory fitness using cardiopulmonary exercise test (CPET). The primary outcomes were changes in percentage body fat and in maximum oxygen uptake (VO).
No statistically significant difference between the placebo and the intervention group regarding changes in percentage body fat (p = 0.54) and VO (p = 0.90) was observed. Moreover, there was no statistically significant difference between the groups concerning changes in BMI (p = 0.26), maximum load (p = 0.89) and oxygen uptake at anaerobic threshold (AT) (p = 0.14).
We conclude that treatment with 2000 IU/d vitamin D for 6 months does not impact body composition or maximum oxygen uptake in overweight/obese men with vitamin D deficiency.
几项观察性研究表明,维生素 D 缺乏与非骨骼主要健康问题之间存在关联,包括心肺功能受损和肥胖。只有少数研究检查了维生素 D 补充对这些情况的影响,结果存在分歧。本研究旨在研究维生素 D 补充对维生素 D 缺乏的超重/肥胖男性的身体成分和心肺功能的影响。
这是一项前瞻性、安慰剂对照、双盲、随机试验,研究期为 6 个月。40 名超重/肥胖男性(BMI>25kg/m)维生素 D 缺乏(25(OH)D≤55nmol/L)随机分为接受 2000IU 胆钙化醇滴剂或等量安慰剂滴剂。在基线和随访时测量身体成分和心肺功能,并采集血液样本。身体成分使用生物电阻抗分析(BIA)测量,心肺功能使用心肺运动测试(CPET)测量。主要结局是体脂百分比和最大摄氧量(VO)的变化。
安慰剂组和干预组在体脂百分比(p=0.54)和 VO(p=0.90)的变化方面无统计学差异。此外,两组在 BMI(p=0.26)、最大负荷(p=0.89)和无氧阈(AT)时的摄氧量(p=0.14)的变化方面无统计学差异。
我们得出结论,6 个月每天服用 2000IU 维生素 D 治疗不会影响维生素 D 缺乏的超重/肥胖男性的身体成分或最大摄氧量。